Product News

Sandoz fully launches in Ireland with plans to grow biosimilars business

Following a 30-year joint venture, Sandoz, the world’s largest generics and biosimilars company, has acquired full ownership of Rowex.

biosimilars

Following a 30-year joint venture, Sandoz, the world’s largest generics and biosimilars company, has acquired full ownership of Rowex.

Rowex has been operating in Bantry, Co. Cork, since 1993 and is one of the leading players in the Irish OTC and generics market.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free